News headlines about St Jude Medical (NYSE:STJ) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. St Jude Medical earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave news coverage about the medical technology company an impact score of 45.9162227188158 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of St Jude Medical stock traded up $0.13 during mid-day trading on Tuesday, hitting $80.82. 14,736,199 shares of the stock were exchanged, compared to its average volume of 8,538,350. St Jude Medical has a 12 month low of $48.83 and a 12 month high of $84.00. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.93 and a quick ratio of 1.31.
St Jude Medical Company Profile
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with MarketBeat.com's FREE daily email newsletter.